Telemedicine Regulations in India: What Doctors Need to Know

Telemedicine in India has evolved into a critical component of healthcare, enhancing clinician-patient interactions and overcoming geographical barriers for real-time medical interventions through digital consultations. It has improved healthcare accessibility, particularly in remote areas, but faces challenges such as the inability to perform physical examinations, which can hinder diagnostics and increase clinician workload.

The Telemedicine Practice Guidelines were made by the Ministry of Health and Family Welfare, NITI Aayog, and the Medical Council of India in March 2020. Registered Medical Practitioners must follow these guidelines as they provide a legal framework to stop professional misconduct.

Key Practice Guidelines for Doctors in India

1. Mandatory Registration Requirements for Doctors Practicing Telemedicine

In India, Registered Medical Practitioners (RMPs) can conduct telemedicine consultations after disclosing their name, qualifications, and registration details. RMPS need to verify the identity of the patient or caregiver before proceeding with consultations.RMPS must complete a specialised online course offered by the Board of Governors within 3 years to practice telemedicine. They also have to show their registration number on different platforms, like prescriptions and electronic communications. This shows that the rules are not always the same, which is not a requirement.

2. Guidelines for Prescribing Medicines via Telemedicine

RMPs are responsible for prescribing medicines through telemedicine, and they must have the required information about the patient. It is misconduct to write prescriptions without a diagnosis.

Telemedicine guidelines have established medicines categorizing them into different lists based on the type of consultation. For example, there is List O, List A, List B, and a list of things that are not allowed. It is mentioned that telemedicine cannot be used to prescribe certain drugs, especially controlled substances and other restricted medications.

Guidelines clearly mentioned which drugs can be given during the first visit and follow-up visits by text, audio, or video. Detailed contents of each list and the associated legal schedules are found in the formal guideline documents and operational guidance.

3. Requirements for Patient Consent and Data Privacy

It is mandatory to obtain patients’ consent for telemedicine consultations, either implied or explicit, based on the context of the teleconsultation. It is RMP's responsibility and the platform to ensure patients’ privacy, comply with data protection laws, and maintain secure records. Implied consent is valid if the patient initiates contact, while explicit consent is needed for clinician-initiated interactions or sensitive information exchanges.

Clinicians must adhere to the Indian Medical Council's conduct rules and relevant data security laws. It is important to maintain Records of consultations, prescriptions, and investigations for legal obligations and continuity of care. Platforms should ensure that there is secure handling of patient data and confidentiality.

4. Different Types of Telemedicine Apps

The guidelines for telemedicine encompass various communication modalities, including text, audio, and video, and categorize consultations as synchronous or asynchronous, each with distinct operational and prescribing ramifications. The choice of communication mode significantly influences the information accessible to the clinician, thereby affecting the scope of diagnosis and prescription capabilities.

Synchronous interactions, such as video or audio consultations, impose different obligations and limitations on prescribing compared to asynchronous methods, like text or store-and-forward communications. These distinctions are integrated into the guidance summaries. Clinically, decisions that require further check-ups, such as new diagnoses necessitating a physical examination, are recommended to be conducted via video or followed up in person, rather than relying solely on text-based exchanges, as indicated by operational commentaries.

5. Prohibited Actions or Medicines Under These Guidelines

Registered Medical Practitioners are prohibited from prescribing Schedule X drugs, as well as any narcotic or psychotropic substances, through teleconsultation, in accordance with the Telemedicine Practice Guidelines. It is considered professional misconduct to prescribe without conducting a thorough clinical evaluation or establishing a provisional diagnosis. Where an in-person consultation is feasible or preferred by the patient, telemedicine should not be mandated.

Confidentiality obligations are violated by any unauthorized disclosure or misuse of patient data, including clinical images. Additionally, physicians are prohibited from soliciting patients through advertisements or inducements for teleconsultation. Furthermore, although technology platforms may facilitate the delivery of care, AI or machine learning tools are incapable of independently prescribing medications or counseling patients; all clinical decisions must be made directly by a Registered Medical Practitioner.

6. Identity Verification Requirements for Doctors and Patients

Verification of identity is a mandatory prerequisite for all telemedicine consultations and must be completed before any clinical interaction or prescription. The responsibility for ensuring correct identification lies with the RMP, particularly in cases where impersonation or misrepresentation may be a concern. In situations involving minors, teleconsultation is permitted only when the minor is accompanied by a verified adult, and the practitioner must explicitly confirm the patient’s age and the identity of the accompanying individual.

Simultaneously, the RMP must ensure transparency of their own identity. At the start of the consultation, the practitioner should clearly disclose their name and qualifications, and must display their registration number issued by the State Medical Council or National Medical Register on all prescriptions, electronic communications, receipts, and digital platforms used for consultation.

7. Ethical Obligations and Professional Responsibilities for Doctors

The guidelines for telemedicine regulations emphasize that established professional ethics apply equally to both teleconsultations and in-person practices. Key obligations include proper documentation, maintaining medical records, obtaining informed consent, and referring patients for in-person evaluations when necessary. Clinicians are expected to charge appropriate fees for teleconsultations, conforming to standard practices.

Additionally, there are strict rules against professional misconduct, including the improper prescribing of controlled substances, which are enforceable under existing regulations. The enforcement of these guidelines may vary depending on local regulatory bodies and professional organizations, highlighting the need for clear operational and legal frameworks.

Conclusion

The introduction of Telemedicine is revolutionizing healthcare in India in a significant way, requiring strategic execution, ethical conduct, and compliance. It leads to scalable growth for healthcare leaders, safe access for patients, and responsible care for doctors. It is a regulated ecosystem that is founded on trust, safety, and responsibility, rather than a digital tool. The goal of the guidelines that have been developed in collaboration with NITI Aayog is to provide RMPs with the necessary support to utilize telemedicine safely and ethically, while also recognizing the importance of clear regulations in this rapidly changing field.

Stay tuned for more such updates on Digital Health News